Mutations typically associated with an indolent ER+/luminal A phenotype, such as CDH1 and MAP3K1 [28], were more frequent in MKSlo/ERShi tumours, consistent with previous data [28, 29]. The gene discussed is MAP3K1; the disease is neoplasm.